Vannevar
Vannevar Labs' flagship product, Decrepyt, is defense software that helps intelligence agents analyze vast data and translate languages.
Secondary Market Price
Secondary Market Price
How Vannevar Measures Up
To help you manage your Vannevar equity, Prospect has run the company through our machine learning model.
Prospect Rating
4X
Our rating for Vannevar Labs is 4X, which means we project it could be worth at least four times its current value in the next four years. For an employee with stock options, this suggests your equity could see a fourfold increase in value.
Exit Risk
Moderate Risk
Our Moderate Risk rating reflects that while Vannevar shows strong signs of success, including profitability and backing from top investors, its focus on a nascent market creates more uncertainty around a future liquidity event compared to startups in more established fields.
Funding Stage
Series B
Vannevar's Series B funding indicates it has a proven product and is now focused on scaling its operations. For you, this means joining a company that's established but still offers substantial opportunities for growth as it expands.
Secondary Market Price Chart
Secondary market prices shown here are a limited preview. Create a free account to access real-time secondary market prices.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Vannevar Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Vannevar's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Vannevar Labs develops software and hardware to address critical national security problems for the United States. The company's flagship product, Decrypt, is a platform that helps intelligence officers analyze vast amounts of battlefield information, translate foreign languages, and search for crucial documents. For example, the U.S. Air Force uses Vannevar's technology to analyze technical documents related to Russia's anti-aircraft systems. The company was founded in 2019 by Brett Granberg, a former venture capitalist at the CIA's investment arm In-Q-Tel, and Nini Hamrick, a former U.S. intelligence officer. They established the mission-driven company to bring top-tier engineering talent to solve complex defense challenges, securing significant funding through seed, Series A, and Series B rounds to fuel its growth.
The company is now at a potential inflection point, scaling quickly with the goal of becoming a market leader in defense technology. With over $25 million in revenue and profitability, Vannevar Labs is focused on rapidly deploying solutions to support active missions, particularly in the context of strategic competition with China. The excitement around the company is backed by recent achievements, including a $75 million Series B funding round in January 2023 and being named to the Forbes Next Billion-Dollar Startups list later that year. These milestones underscore the company's trajectory and its growing importance in the national security space.
- Felicis
- General Catalyst
- DFJ Growth
- Point752 Ventures
- Shield Capital
- Aloft VC
- Co-Founder, CEO Brett Granberg
- Co-Founder, Nini Hamrick
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Vannevar worth joining?
Vannevar Labs is a profitable, mission-driven company with over $25M in revenue and is considered to be at a potential growth inflection point. To evaluate a potential equity offer, you can use a platform like Prospect, which provides independent, data-driven projections on what your equity could be worth.
What should I do with my Vannevar stock?
Managing private company stock involves complex decisions regarding tax implications and timing. Prospect offers tools that help create personalized option exercise strategies and minimize tax burdens to maximize your equity's value.
Can you sell Vannevar stock?
Since Vannevar is a private company, its stock is not traded on public exchanges, but sales can sometimes occur on secondary markets. Platforms like Prospect can provide data on secondary market prices to help inform selling decisions.
How can I find the value of my Vannevar stock?
The value of your stock is based on the company's latest valuation, which is between $500M and $1B. For a more personalized estimate, Prospect's equity tools use comprehensive data to project what your individual holdings might be worth.
What is Vannevar's equity worth?
The company's total equity is valued between $500M and $1B, based on its Series B funding round. To understand the potential value of your specific shares, you can review the company's full profile and use predictive models from platforms like Prospect.
What is Vannevar's stock ticker symbol?
Vannevar Labs does not have a stock ticker symbol. This is because it is a private company and its shares are not available for trading on public stock exchanges.
Can I buy or sell Vannevar stock?
As a private company, Vannevar stock is not publicly traded, but selling may be possible through secondary markets. Resources like Prospect provide data on secondary market pricing to help employees navigate potential sales.
What is the criteria to buy or invest in Vannevar stock?
Since Vannevar is a privately held, venture-backed company, direct investment is generally not open to the public. Participation in funding rounds is typically restricted to institutional or accredited investors.
